Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines

BACKGROUND: Two cytidine analogues, gemcitabine and cytosine arabinoside (AraC), are widely used in the treatment of a variety of cancers with a large individual variation in response. To identify potential genetic biomarkers associated with response to these two drugs, we used a human lymphoblastoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Liang, Fridley, Brooke L, Kalari, Krishna, Niu, Nifang, Jenkins, Gregory, Batzler, Anthony, Abo, Ryan P, Schaid, Daniel, Wang, Liewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930546/
https://www.ncbi.nlm.nih.gov/pubmed/24483146
http://dx.doi.org/10.1186/1471-2164-15-93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930546/
https://www.ncbi.nlm.nih.gov/pubmed/24483146
http://dx.doi.org/10.1186/1471-2164-15-93

Ejemplares similares